Alternative-protein production

Chlorella, spirulina and specialty microalgae strains are being processed into functional protein isolates and pigmented ingredients for bakery, meat-analogue and nutraceutical food applications — distinct from the omega-3-lipid-focused microalgae-for-aquafeed industry.

Plant-based and fermentation-derived protein sources designed to replicate the sensory and nutritional profiles of animal products.

Genuine fish, crustacean and mollusc tissue grown from fish cells in bioreactors, offering sushi-grade seafood without fishing pressure on wild stocks or the feed-fish burden of aquaculture.

Industrial-scale black soldier fly and mealworm farming is going through a hard correction in 2026 — a flagship European originator collapsed into insolvency and a flagship North American cricket plant entered receivership — even as an Indian entrant reports fast, capital-efficient growth.

Cricket bars, mealworm snacks, cricket pasta and chips — high-protein (~65%) insect-based snacks positioned on a fraction of the land, water and feed of conventional protein, led by a consolidated European specialist-brand set (Jimini's, Crické, Seek, Sens) and Chapul after several US high-profile failures.

Conventional meat processors blending animal protein with pea, soy and chickpea isolates into 50/50 hybrid sausages, schnitzel, nuggets and meatballs — the flexitarian FMCG carve-out pioneered by Rügenwalder's Halb & Halb, now spreading to Perdue, Maple Leaf and Tyson as the hybrid meat market heads toward USD 1.68 bn by 2036.

Fungal biomass protein (mycoprotein) and mycelium materials produced via fermentation of Fusarium, Neurospora and Trichoderma — a $4.6B market growing at 12% CAGR.

Precision fermentation is scaling up intensely sweet, calorie-free plant proteins as sugar replacements — a US platform's third FDA no-questions letter for brazzein, Europe's first commercial-scale brazzein factory under construction in Lithuania, and an Israeli engineered sweet protein clearing FDA GRAS and Singapore approval with published blood-glucose safety data.